New microfluidic device for lactate dehydrogenase (LDH) activity analysis
暂无分享,去创建一个
[1] H. Wolterbeek,et al. Optimization, application, and interpretation of lactate dehydrogenase measurements in microwell determination of cell number and toxicity. , 2005, Assay and drug development technologies.
[2] Elisabeth Verpoorte,et al. Microfluidic biochip for the perifusion of precision‐cut rat liver slices for metabolism and toxicology studies , 2010, Biotechnology and bioengineering.
[3] Gale Haslam,et al. Estimating the number of viable animal cells in multi-well cultures based on their lactate dehydrogenase activities , 2004, Cytotechnology.
[4] V. Adleff,et al. Enhancement of 5-Fluorouracil Efficacy on High COX-2 Expressing HCA-7 Cells by Low Dose Indomethacin and NS-398 but not on Low COX-2 Expressing HT-29 Cells , 2009, Pathology & Oncology Research.
[5] John Greenman,et al. Study of ethanol induced toxicity in liver explants using microfluidic devices , 2011, Biomedical microdevices.
[6] Andrew L. Niles,et al. In Vitro Viability and Cytotoxicity Testing and Same-Well Multi-Parametric Combinations for High Throughput Screening , 2009, Current chemical genomics.
[7] Andreas Zimmer,et al. A practical note on the use of cytotoxicity assays. , 2005, International journal of pharmaceutics.
[8] Hannu Uusitalo,et al. The effects of 5-fluorouracil on ocular tissues in vitro and in vivo after controlled release from a multifunctional implant. , 2009, Investigative ophthalmology & visual science.
[9] Soo-Jeong Lim,et al. Cyclooxygenase-independent down-regulation of multidrug resistance–associated protein-1 expression by celecoxib in human lung cancer cells , 2005, Molecular Cancer Therapeutics.
[10] J. Pfeilschifter,et al. Cerivastatin inhibits proliferation of interleukin-1 beta-induced rat mesangial cells by enhanced formation of nitric oxide. , 2004, European journal of pharmacology.
[11] J. Rhee,et al. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. , 2007, World journal of gastroenterology.
[12] M Balls,et al. Methods of in vitro toxicology. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[13] Sanjeev Kumar Mahto,et al. in vitromodels, endpoints and assessment methods for the measurement of cytotoxicity , 2010, Toxicology and Environmental Health Sciences.
[14] J. B. Griffiths,et al. Use of lactate dehydrogenase release to assess changes in culture viability , 1990, Cytotechnology.
[15] Michal Chudy,et al. PDMS/glass microfluidic cell culture system for cytotoxicity tests and cells passage , 2010 .
[16] Laurent Griscom,et al. Behavior of HepG2/C3A cell cultures in a microfluidic bioreactor , 2011 .
[17] John Greenman,et al. A Microfluidic System for Testing the Responses of Head and Neck Squamous Cell Carcinoma Tissue Biopsies to Treatment with Chemotherapy Drugs , 2011, Annals of Biomedical Engineering.
[18] Brian B. Hasinoff,et al. The cytotoxicity of celecoxib towards cardiac myocytes is cyclooxygenase-2 independent , 2007, Cardiovascular Toxicology.